Ecovyst lifted its full‑year sales guidance to $970 million, a 9% increase from the prior $890 million target. The boost mirrors a 42% jump in Q2 revenue and a strategic acquisition, expanding the firm’s top‑line runway and raising potential upside for shareholders.
Key Highlights
- Q2 sales rose 42% to $250.0 million, adding $73.9 million YoY
- Adjusted EBITDA climbed 27% to $53.1 million, up $11.2 million
- Cash from operations hit $55.2 million for six months, more than double the prior‑year period
Ecovyst Inc. (NYSE: ECVT) announced a 9% lift in its 2026 sales outlook, moving the target from $890 million to $970 million, while quarterly revenue surged 42% to $250.0 million. This dual momentum of guidance expansion and strong top‑line growth positions the firm for a stronger second half as it integrates recent acquisitions.
Guidance
Boost The revised sales guidance now sits at $970 million, reflecting a 9% increase from the previous $890 million target. Management cites higher sulfur pricing and the recent Calabrian acquisition as primary drivers. The new outlook dovetails with an adjusted EBITDA range of $195 million to $207 million, up from $180 million to $195 million, signaling an expanded earnings horizon.
Investors will see the guidance hike as a direct translation of the 42% revenue jump, enhancing the valuation multiple applied to future cash flows. This uplift also narrows the gap between projected and historical performance, tightening the growth narrative.
Revenue Surge
Quarterly sales climbed $73.9 million to $250.0 million, powered by stronger volumes of regenerated and virgin sulfuric acid. Higher average selling prices, driven by a $55 million pass‑through of increased sulfur costs, amplified revenue despite inflationary pressures. The Waggaman plant’s contribution and reduced customer downtime boosted regenerated acid sales, while virgin acid volume rose double‑digits.
This revenue acceleration supports the guidance increase and underscores the firm’s capacity to capture pricing tailwinds without sacrificing margins.
Cash Flow and Leverage
Operating cash flow for the six‑month period reached $55.2 million, more than twice the $25.3 million generated a year earlier, reflecting stronger earnings and disciplined working capital. The company held $87.8 million in cash and equivalents and retained $88.5 million of availability under its asset‑based lending facility, delivering total available liquidity of $176.3 million. Gross debt stood at $497.1 million, yielding a net‑debt leverage ratio of 2.0x and a net‑debt to net‑income ratio of 15.9x, up from 1.2x at year‑end 2025 due to a $100 million term loan tied to the Calabrian purchase.
These metrics illustrate the balance between growth financing and debt discipline, a key consideration for credit‑sensitive investors.
Upcoming Catalyst
The next quarterly earnings release, slated for the third quarter, will test whether the Calabrian acquisition contributes the anticipated $10 million to $12 million of adjusted EBITDA in the second half of 2026. Analysts will also watch the company’s ability to sustain its 27% adjusted EBITDA growth and manage the elevated leverage ratio amid continued sulfur price volatility. Sector peers NGVT and MTX showed little change on the day, offering a comparative backdrop as investors gauge Ecovyst’s relative performance.
The upcoming results will clarify if the guidance expansion translates into tangible earnings momentum and will likely influence share price movement within the $7.41‑$15.09 52‑week range.
Peers Moving on This News
- Ingevity Corp (NGVT) little changed
- Minerals Technologies Inc (MTX) little changed
Analysis based on the Form 8-K filed 5 August 2026.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.






Please wait processing your request...